Proud to have been faculty for this amazing workshop for three years running - great fun as always working with amazing colleagues @Reidmeanna @JWeirMcCall @AIhdayhid followed by an excellent #SCCT2025 meeting

Phenomenal Structural Heart Session with outstanding global leaders @JohnJeffreyCarr @rooshaparikh @Reidmeanna @AIhdayhid at #SCCT2025 @Heart_SCCT with topics ranging from TAVR, TMVR and LAAO devices - practical insights highlighting the power of #YesCCT

🫀 Practical and high-yield sessions at #SCCT2025 — Dr. Abdul Ihdayhid @AIhdayhid shared expert insight on CT planning for valve-in-valve TAVR and coronary protection. 👉 Why it matters: Coronary obstruction is rare but devastating, with ~50% mortality if it occurs during TAVR.

🫀New CAC-DAD score using deep learning outperforms the Agatston score in predicting MACE! ✅ Accounts for plaque distribution + density 📊 Identifies high-risk pts missed by AS≥400 @cardiacimager @VictorChangInst @PerkinsComms @HeartInstitute https://t.co/7A9UOyVAhX

Just presented at TCT and published in NEJM by @PhilGenereuxMD showing superiority of early TAVR in asymptomatic severe AS. This trial will change the guidelines !

In this study of 44,742 patients, 📊 high lipoprotein(a) levels (>100 mg/dL) are linked to a 2x ⬆️ risk of severe degenerative aortic stenosis & need for aortic valve replacement https://t.co/zjrd4L2AkV #vhdAS #AVR #cvLipids #JACCAsia

🔥FFR with PPG for detecting vulnerable plaques @JACCJournals 💡The more severe and focal the disease, the higher the likelihood of a high-risk plaque. 🛟In diffuse disease (low PPG), the chance of a high-risk plaque drops significantly. @PCRonline https://t.co/OxRNlwzOPE

Join host @Reidmeanna & guest host @CsFuss as they take a deep dive into featured articles in the July – August 2024 issue of the @journalCCT. Our hosts chat with @DrNaghavi and @AIhdayhid. Listen here:

New work in @JACCJournals highlights use of CT to assess fibro-calcific disease in AS - import new work to understand valve pathophysiology https://t.co/JgrOq9cA15 https://t.co/vq31mroBnK @neiljcraig @marc @uniofedinburgh @David_Meier_ @imagingmedsci @damini_dey

September 18th, join Computational Modeling in TAVR webinar with: @AIhdayhid @DrHodaHatoum and @Zahra_Motamed. @David_Meier_ and @sellers_steph moderate https://t.co/aJ7PLMQ1jc @ubc_cci @HLIStPauls @Providence_Hlth @CardioUBC @UBCDoM @CHVI85209027 #TAVR #webinar #vivitrolabs

✨Early #AVR in Moderate AS with LVEF<50% was associated with 2 fold ⬇️ in Mortality vs Clinical Survillance over 10 yrs f/u‼️Glad to share our pooled analysis 📜 @JACCJournals led by @PPibarot @MartyBLeon @ClavelLabo @PhilGenereuxMD @tavrkapadia @drnvanmieghem

This study by Ko et al demonstrates the usefulness of CCTA for guiding PCI interventions and stent sizing. https://t.co/RxRr4YvaQn

He et al reviews the role of cardiac CT angiography in the post-TAVR period for its utility for long-term TAVR monitoring and risk stratification for future invasive procedures. https://t.co/RK2dwMqDIM

THE PAPER to download NOW @JACCJournals #JACCINT Redo-TAV app SOTA review by @bapat_savrtavr @Miho_Fukui_ @SyedZaidMD @TheLADoctor @OKhaliqueMD @JoaoLCavalcante @LandesUri @J_Sathananthan @G_Tarantini01 @TheDoctorMack @MartyBLeon et al https://t.co/L3EGQENt58

🔥 Just out of press: Pushing the field forward 💪 Great work by Brian Ko @MonashUni and @HiroOhashi Stent sizing by coronary CT angiography compared with optical coherence

@thecsanz 2024 meeting @WestAustralia already coming together with @cardiacimager and brilliant organising committee - @theconferenceco @AIhdayhid @Grahamhillis1 @LeeNedkoff @DrNikkiBart @dr_adil_rajwani @RukyEPdoc and others. International Star speakers will be announced soon!

Time to Tx high #CAC as aggressively as post-heart attack? CAC of ≥300 in asymptomatic ppl confers the same risk as post-MI survivors (eg secondary prevention) in #CONFIRM. Use of CAC may guide the intensity of preventive approaches more broadly. https://t.co/g0U3JcSW4Q #JACCIMG

A #JACCINT study investigated the predicted vs observed valve-to-coronary distance in valve-in-valve #TAVR. Preprocedural CT assessment may not fully predict postprocedural expansion. Check out the results: https://t.co/qU9qpq7yD0 #CardioTwitter @tzimas_georgios

Read our study on how young STEMI patients without Standard Modifiable Risk Factors (SMuRFs) have worse outcomes! https://t.co/UHto5k7OWF @cardiacimager @AIhdayhid @AmJCardio

#CoronaryPhysiology #ComputedTomographyCoronaryAngiography #EM FIRST-LINE C T C A in the ED ⬆️outpatient CTCA ⬇️downstream investigations 🟰rates of ICA ⬆️change in preventive therapies ⬆️significant CAD on ICA 👇 https://t.co/7y1xNhuzLa 👋 NSR Lan @AIhdayhid 🇦🇺